logo

COVID-19 research

Our research group worked in collaboration with the Institut national de santé publique du Québec (INSPQ) on many different aspects of COVID-19 research. Find out about our results, including the most recent, in these reports.

News

September 2023
PRESENTATION AT THE NACI HPV WORKGROUP MEETING

Marc Brisson presented to the Canadian National Advisory Committee on Immunization (NACI) HPV workgroup meeting on September 18, 2023: “Potential impact of switching from a 2-dose to 1-dose routine HPV vaccination program in Canada”.

September 2023
PRESENTATION AT THE CIQ MEETING

Marc Brisson participated to the Comité sur l’immunisation du Québec (CIQ) meeting held in Montreal, September 15, 2023. He presented “Potential impact of switching from a 2-dose to 1-dose routine HPV vaccination program in Québec”.

September 2023
PRESENTATION AT WHO IVIR-AC MEETING

Marc Brisson participated to the Immunization and Vaccines Related Implementation Research Advisory Committee (IVIR-AC) of the World Health Organization (WHO) held in Geneva, September 11-15, 2023. He presented “Mathematical modeling of COVID-19 in Burkina Faso and Cameroon”. [ WHO ]

August 2023
PUBLICATION IN BMC MEDICINE

‘Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis’ [ BMC Med ]

May 2023
CIRN GRANT

Marc Brisson was awarded a CIHR Canadian Immunization Research Network (CIRN) Grant: “Optimization of HPV vaccination and screening in Canada, considering opportunities provided by 1-dose vaccination: A mathematical modeling study”.